Kimelman & Baird’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.6M | Hold |
160,179
| – | – | 1.52% | 25 |
|
|
2026
Q1 | $19.3M | Hold |
160,179
| – | – | 1.59% | 26 |
|
|
2025
Q4 | $16.9M | Sell |
160,179
-2,271
| -1% | -$213K | 1.3% | 26 |
|
|
2025
Q3 | $13.6M | Hold |
162,450
| – | – | 1.06% | 29 |
|
|
2025
Q2 | $12.9M | Sell |
162,450
-100
| -0.1% | -$7.95K | 1.05% | 28 |
|
|
2025
Q1 | $14.6M | Hold |
162,550
| – | – | 1.24% | 26 |
|
|
2024
Q4 | $16.2M | Sell |
162,550
-350
| -0.2% | -$36.1K | 1.29% | 25 |
|
|
2024
Q3 | $18.5M | Sell |
162,900
-660
| -0.4% | -$78.4K | 1.48% | 24 |
|
|
2024
Q2 | $20.2M | Buy |
+163,560
| New | +$21.1M | 1.67% | 22 |
|
|
2021
Q2 | $13.5M | Buy |
+174,129
| New | +$13M | 1.21% | 32 |
|
|
2019
Q3 | $14.3M | Sell |
177,721
-105
| -0.1% | -$8.41K | 1.98% | 23 |
|
|
2019
Q2 | $14.2M | Sell |
177,826
-2,410
| -1% | -$185K | 1.98% | 22 |
|
|
2019
Q1 | $14.3M | Sell |
180,236
-1,572
| -0.9% | -$118K | 2.06% | 20 |
|
|
2018
Q4 | $13.3M | Buy |
181,808
+210
| +0.1% | +$14.8K | 2.06% | 22 |
|
|
2018
Q3 | $12.3M | Sell |
181,598
-3,983
| -2% | -$254K | 1.55% | 27 |
|
|
2018
Q2 | $10.7M | Buy |
+185,581
| New | +$10.5M | 1.41% | 28 |
|
|
2017
Q4 | $10.3M | Sell |
191,277
-27,273
| -12% | -$1.51M | 1.46% | 27 |
|
|
2017
Q3 | $13.4M | Buy |
218,550
+23,815
| +12% | +$1.44M | 1.99% | 19 |
|
|
2017
Q2 | $11.9M | Buy |
194,735
+5,816
| +3% | +$354K | 1.8% | 22 |
|
|
2017
Q1 | $11.5M | Sell |
188,919
-887
| -0.5% | -$53.8K | 1.74% | 23 |
|
|
2016
Q4 | $10.7M | Sell |
189,806
-5,215
| -3% | -$305K | 1.79% | 23 |
|
|
2016
Q3 | $11.6M | Sell |
195,021
-472
| -0.2% | -$27.6K | 2.04% | 18 |
|
|
2016
Q2 | $10.7M | Hold |
195,493
| – | – | 1.96% | 17 |
|
|
2016
Q1 | $9.87M | Hold |
195,493
| – | – | 1.84% | 18 |
|
|
2015
Q4 | $9.85M | Buy |
+195,493
| New | +$9.86M | 1.85% | 17 |
|
|
2015
Q2 | $10.6M | Buy |
195,493
+4,064
| +2% | +$228K | 1.81% | 19 |
|
|
2015
Q1 | $10.5M | Hold |
191,429
| – | – | 1.91% | 18 |
|
|
2014
Q4 | $10.4M | Hold |
191,429
| – | – | 1.87% | 16 |
|
|
2014
Q3 | $10.8M | Hold |
191,429
| – | – | 2.05% | 15 |
|
|
2014
Q2 | $10.6M | Hold |
191,429
| – | – | 1.86% | 18 |
|
|
2014
Q1 | $10.4M | Sell |
191,429
-524
| -0.3% | -$27.1K | 1.93% | 17 |
|
|
2013
Q4 | $9.17M | Hold |
191,953
| – | – | 1.75% | 21 |
|
|
2013
Q3 | $8.72M | Hold |
191,953
| – | – | 1.74% | 23 |
|
|
2013
Q2 | $8.51M | Buy |
+191,953
| New | +$8.57M | 1.79% | 23 |
|
Other funds holding MRK
Kimelman & Baird's MRK Position: Q2 2026 in Review
Kimelman & Baird held its Merck (MRK) position steady in Q2 2026 at 160,179 shares worth $20.6M. The position accounts for 1.52% of the portfolio, ranked #25.
Kimelman & Baird first reported a position in MRK in Q2 2013 and has held it in 34 quarters since. 3,819 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Kimelman & Baird held 160,179 shares of Merck worth $20.6M as of Q2 2026.
- Kimelman & Baird left its Merck share count unchanged in Q2 2026.
- Merck made up 1.52% of Kimelman & Baird's portfolio in Q2 2026, its #25 holding.
- Kimelman & Baird first reported a position in Merck in Q2 2013 and has held it in 34 quarters since.
- 3,819 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Kimelman & Baird's 13F filing for Q2 2026, filed 5 Aug 2026.